BREASTSENTRY Trademark

Trademark Overview

On Tuesday, March 17, 2015, a trademark application was filed for BREASTSENTRY with the United States Patent and Trademark Office. The USPTO has given the BREASTSENTRY trademark a serial number of 86566524. The federal status of this trademark filing is REGISTERED as of Tuesday, October 22, 2019. This trademark is owned by GENENEWS LIMITED. The BREASTSENTRY trademark is filed in the Medical Instrument Products and Computer & Software Services & Scientific Services categories with the following description:

Kits comprising blood drawing apparatus and molecular biological reagents useful for detecting gene expression products, namely, ribonucleic acid (RNA), copy deoxyribonucleotic acids (cDNA), polymerase chain reaction (PCR) products or proteins, as an indication of body state, namely, body health, condition, disease or response to therapeutic treatment, particularly with regard to breast disease and including breast cancer

Providing medical testing services in the field of cancer research and disease classification, namely, monitoring and predicting disease and risk of disease, identifying risk factors of disease, prognostic testing, gene and/or protein testing and identifying physiological characteristics, particularly as each relates to breast disease including breast cancer
breastsentry

General Information

Serial Number86566524
Word MarkBREASTSENTRY
Filing DateTuesday, March 17, 2015
Status700 - REGISTERED
Status DateTuesday, October 22, 2019
Registration Number5891462
Registration DateTuesday, October 22, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 17, 2018

Trademark Statements

Goods and ServicesKits comprising blood drawing apparatus and molecular biological reagents useful for detecting gene expression products, namely, ribonucleic acid (RNA), copy deoxyribonucleotic acids (cDNA), polymerase chain reaction (PCR) products or proteins, as an indication of body state, namely, body health, condition, disease or response to therapeutic treatment, particularly with regard to breast disease and including breast cancer
Goods and ServicesProviding medical testing services in the field of cancer research and disease classification, namely, monitoring and predicting disease and risk of disease, identifying risk factors of disease, prognostic testing, gene and/or protein testing and identifying physiological characteristics, particularly as each relates to breast disease including breast cancer
Pseudo MarkBREAST SENTRY

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, July 20, 2017
Primary Code010
First Use Anywhere DateTuesday, June 27, 2017
First Use In Commerce DateTuesday, June 27, 2017
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 20, 2017
Primary Code042
First Use Anywhere DateTuesday, June 27, 2017
First Use In Commerce DateTuesday, June 27, 2017

Trademark Owner History

Party NameGENENEWS LIMITED
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRichmond Hill, Ontario L4B3B2
CA
Party NameGENENEWS LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMarkham, Ontario L3R9X7
CA
Party NameGENENEWS LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMarkham, Ontario L3R9X7
CA

Trademark Events

Event DateEvent Description
Wednesday, February 5, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 5, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 22, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, October 2, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, September 20, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, September 19, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 5, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 5, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 15, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 15, 2019NON-FINAL ACTION E-MAILED
Monday, July 15, 2019SU - NON-FINAL ACTION - WRITTEN
Wednesday, June 26, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 26, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 25, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 14, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 14, 2019NON-FINAL ACTION E-MAILED
Monday, January 14, 2019SU - NON-FINAL ACTION - WRITTEN
Friday, January 11, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, December 10, 2018USE AMENDMENT FILED
Friday, January 11, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 10, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, June 12, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 17, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 17, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 13, 2018ELECTRONIC RECORD REVIEW COMPLETE
Friday, March 9, 2018ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, March 5, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 1, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 1, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 28, 2018ASSIGNED TO LIE
Friday, February 16, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, January 11, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, January 11, 2018LETTER OF SUSPENSION E-MAILED
Thursday, January 11, 2018SUSPENSION LETTER WRITTEN
Wednesday, January 10, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, January 10, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, January 10, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 10, 2018EXAMINERS AMENDMENT E-MAILED
Wednesday, January 10, 2018EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 3, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 2, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 2, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, July 31, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, July 31, 2017FINAL REFUSAL E-MAILED
Monday, July 31, 2017FINAL REFUSAL WRITTEN
Thursday, July 20, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 20, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 20, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, February 9, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, July 7, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, January 5, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 5, 2016LETTER OF SUSPENSION E-MAILED
Tuesday, January 5, 2016SUSPENSION LETTER WRITTEN
Tuesday, December 15, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 15, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 14, 2015ASSIGNED TO LIE
Tuesday, December 1, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 22, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 22, 2015NON-FINAL ACTION E-MAILED
Monday, June 22, 2015NON-FINAL ACTION WRITTEN
Saturday, June 20, 2015ASSIGNED TO EXAMINER
Friday, March 27, 2015NOTICE OF PSEUDO MARK E-MAILED
Thursday, March 26, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

breastsentry disease breast cancer namely testing gene risk products identifying particularly